212 related articles for article (PubMed ID: 33098884)
41. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States.
Galoosian A; Rezapour M; Liu B; Bhuket T; Wong RJ
J Clin Gastroenterol; 2020 Aug; 54(7):e63-e72. PubMed ID: 31008866
[TBL] [Abstract][Full Text] [Related]
42. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.
Ye Y; Manne S; Treem WR; Bennett D
Inflamm Bowel Dis; 2020 Mar; 26(4):619-625. PubMed ID: 31504515
[TBL] [Abstract][Full Text] [Related]
44. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Lytras T; Bonovas S
Gastroenterology; 2019 Sep; 157(3):647-659.e4. PubMed ID: 31014995
[TBL] [Abstract][Full Text] [Related]
45. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
46. Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.
Balderramo D; Quaresma AB; Olivera PA; Savio MC; Villamil MPG; Panaccione R; Ng SC; Kaplan GG; Kotze PG
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):263-272. PubMed ID: 38340754
[TBL] [Abstract][Full Text] [Related]
47. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
48. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
49. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
[TBL] [Abstract][Full Text] [Related]
50. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
Han M; Jung YS; Cheon JH; Park S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
[TBL] [Abstract][Full Text] [Related]
51. Incidence and prevalence of inflammatory bowel diseases in gastroenterology primary care setting.
Tursi A; Elisei W; Picchio M
Eur J Intern Med; 2013 Dec; 24(8):852-6. PubMed ID: 23867759
[TBL] [Abstract][Full Text] [Related]
52. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
[TBL] [Abstract][Full Text] [Related]
53. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory Bowel Disease as a Precondition for Stroke or TIA: A Matter of Crohn's Disease Rather than Ulcerative Colitis.
Tanislav C; Trommer K; Labenz C; Kostev K
J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105787. PubMed ID: 33865232
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
56. Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study.
Lirhus SS; Høivik ML; Moum B; Melberg HO
Scand J Gastroenterol; 2018 Aug; 53(8):952-957. PubMed ID: 30205699
[TBL] [Abstract][Full Text] [Related]
57. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
[TBL] [Abstract][Full Text] [Related]
58. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease.
Zhao J; Ng SC; Lei Y; Yi F; Li J; Yu L; Zou K; Dan Z; Dai M; Ding Y; Song M; Mei Q; Fang X; Liu H; Shi Z; Zhou R; Xia M; Wu Q; Xiong Z; Zhu W; Deng L; Kamm MA; Xia B
Inflamm Bowel Dis; 2013 Aug; 19(9):1839-45. PubMed ID: 23669403
[TBL] [Abstract][Full Text] [Related]
59. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.
Moum B; Ekbom A; Vatn MH; Aadland E; Sauar J; Lygren I; Schulz T; Stray N; Fausa O
Scand J Gastroenterol; 1997 Oct; 32(10):1005-12. PubMed ID: 9361173
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
